These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 303962)

  • 1. Enzymatic concept of otospongiosis and cochlear otospongiosis.
    Causse J; Chevance LG; Bretlau P; Jorgensen MB; Uriel J; Berges J
    Clin Otolaryngol Allied Sci; 1977 Feb; 2(1):23-32. PubMed ID: 303962
    [No Abstract]   [Full Text] [Related]  

  • 2. [A biochemical and cytological explanation of cochlear otospongiosis].
    Chevance LG
    Acta Otolaryngol; 1976; 81(3-4):200-3. PubMed ID: 1083621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymology of otospongiosis and NaF therapy.
    Causse JR; Shambaugh GE; Causse B; Bretlau P
    Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensorineural hearing loss due to cochlear otospongiosis: etiology.
    Causse JR; Chevance LG
    Otolaryngol Clin North Am; 1978 Feb; 11(1):125-34. PubMed ID: 662340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha 1-antitrypsin activity of perilymph. Occurrence during progression of otospongiosis.
    Chevance LG; Causse JR; Bergès J
    Arch Otolaryngol; 1976 Jun; 102(6):363-4. PubMed ID: 1084149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enzymatic mechanism of otosclerosis. Action of NaF].
    Causse JR; Uriel J; Berges J; Bretlau P; Causse JB
    Ann Otolaryngol Chir Cervicofac; 1981; 98(6):269-97. PubMed ID: 6174065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies on fluoride in otospongiosis.
    Causse JR; Causse JB
    Am J Otol; 1985 Jan; 6(1):51-5. PubMed ID: 2579565
    [No Abstract]   [Full Text] [Related]  

  • 9. The enzymatic mechanism of the otospongiotic disease and NaF action on the enzymatic balance.
    Causse JR; Uriel J; Berges J; Shambaugh GE; Bretlau P; Causse JB
    Am J Otol; 1982 Apr; 3(4):297-314. PubMed ID: 6177249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Otospongiosis, a cellular and enzymatic lysosomal disease. Cyto-clinical correlation].
    Chevance LG; Causse J; Jorgensen MB; Bretlau P
    Ann Otolaryngol Chir Cervicofac; 1972; 89(1):5-34. PubMed ID: 4537996
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental studies on pathology and therapy of otospongiosis.
    Petrovic AG; Stutzmann JJ; Shambaugh GE
    Am J Otol; 1985 Jan; 6(1):43-50. PubMed ID: 2983562
    [No Abstract]   [Full Text] [Related]  

  • 12. [Otospongiosis, a lysosomal disease].
    Chevance LG; Jorgensen MB; Causse J
    Acta Otorhinolaryngol Belg; 1971; 25(4):600-3. PubMed ID: 5143645
    [No Abstract]   [Full Text] [Related]  

  • 13. Otosclerosis. Histopathology, light and electron microscopy.
    Friedmann I
    Acta Otorhinolaryngol Belg; 1981; 35(5-6):419-30. PubMed ID: 7347084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteolytic activity of the perilymph in patients with otosclerosis after conservative therapy].
    Galochkin VI
    Vestn Otorinolaringol; 1987; (1):15-8. PubMed ID: 3551287
    [No Abstract]   [Full Text] [Related]  

  • 15. [A biochemical and cytological explanation of cochlear otospongiosis].
    Chevance LG; Causse J; Berges J; Manach Y; Adrian M
    Ann Otolaryngol Chir Cervicofac; 1976; 93(4-5):275-87. PubMed ID: 1085115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear otospongiosis etiology, diagnosis and therapeutic implications.
    Causse J; Shambaugh GE; Chevance LG; Bretlau P
    Adv Otorhinolaryngol; 1977; 22():43-56. PubMed ID: 868708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis).
    Causse J; Chevance LG; Shambaugh GE
    Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470
    [No Abstract]   [Full Text] [Related]  

  • 18. Otosclerosis: a review.
    Soifer N; Weaver K; Endahl GL; Holdsworth CE
    Acta Otolaryngol Suppl; 1970; 269():1-25. PubMed ID: 4321400
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrolytic activity of the perilymph in otosclerosis. A preliminary report.
    Chevance LG; Causse J; Bretlau P; Jorgensen MB; Bergés J
    Acta Otolaryngol; 1972; 74(1):23-8. PubMed ID: 4341581
    [No Abstract]   [Full Text] [Related]  

  • 20. Otospongiosis (otosclerosis): polytomographic and histologic correlation.
    Applebaum EL; Shambaugh GE
    Laryngoscope; 1978 Nov; 88(11):1761-8. PubMed ID: 713672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.